Luna S. Pane
BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Author Correction: Universal toxin-based selection for precise genome engineering in human cells.
Journal: Nature communications
Published: May 11, 2021
Universal toxin-based selection for precise genome engineering in human cells.
Journal: Nature communications
Published: April 21, 2020
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model.
Journal: BMC biology
Published: October 22, 2018
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
Journal: PloS one
Published: May 22, 2018
Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer.
Journal: Disease models & mechanisms
Published: March 16, 2017
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Journal: Cardiovascular research
Published: April 19, 2016
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
Journal: European heart journal
Published: February 06, 2016
Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.
Journal: EMBO molecular medicine
Published: March 12, 2015
Embryonic heart progenitors and cardiogenesis.
Journal: Cold Spring Harbor perspectives in medicine
Published: October 03, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026